While both cDC1 and cDC2 cells can capture tumor antigens, the cDC1 subset is unique in its ability to efficiently phagocytose and process cell-associated antigens and present antigen-derived peptides on class I MHC molecules to CD8 T cells in a process termed cross-presentation (22). The gene discussed is CD8A; the disease is neoplasm.